CRISPR Therapeutics AGCRSPNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P27
Within normal range
vs 2Y Ago
-2.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -139.11% |
| 2024 | 46.39% |
| 2023 | 49.37% |
| 2022 | -216.55% |
| 2021 | 278.12% |
| 2020 | -613.52% |
| 2019 | 150.49% |
| 2018 | -27.08% |
| 2017 | -33.58% |
| 2016 | -200.09% |